netFormulary Harrogate & Rural District Formulary NHS
Harrogate & District NHS Foundation Trust
Harrogate & Rural District Clinical Commissioning Group
 
 
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Notes:

Guidelines for the Management of Antipsychotic-Induced Hyperprolactinaemia

Chapter Links...
 Details...
04.09.01  Expand sub section  Dopaminergic drugs used in Parkinsons disease
 note 

Medicines management of the Parkinsons patient - HDFT guidelines

Parkinsons patients - information for Pharmacists 

04.09.01  Expand sub section  Dopamine receptor agonists
Apomorphine Hydrochloride (APO-go®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Amber Shared Care
Injection 20mg/2ml, 50mg/5ml

Initiation on the advice of a specialist 
Link  HDFT Apomorphine Prescription Chart
Link  Apomorphine step by step pump set-up guide
Link  Apomorphine - Setting the flow rate guide
Link  Apomorphine abbreviated user guide
   
Cabergoline
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber
Tablets 500micrograms

Initiation on the advice of a specialist 
   
Pramipexole
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Amber
Tablets 180micogram base (= 250micogram salt),
700micogram base (= 1000microgram salt)

Initiation on the advice of a specialist


MR formulation: Individual patient request required through LPG. Preferred product of choice in primary care is Pipexus MR 
   
Ropinirole
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Amber
Tablets 250micrograms, 1mg

Initiation on the advice of a specialist 
   
Ropinirole MR (XL)  (Ipnnia XL®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Amber
2mg, 3mg, 4mg, 6mg and 8mg tablets 
   
Rotigotine (Neupro®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber
Patches 2mg, 4mg, 6mg, 8mg

Initiation on the advice of a specialist 
   
04.09.01  Expand sub section  Levodopa
04.09.01  Expand sub section  Monoamine-oxidase-B inhibitors
04.09.01  Expand sub section  Catachol-O-methyltransferase inhibitors to top
04.09.01  Expand sub section  Amantadine
 ....
 Non Formulary Items
Bromocriptine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cabergoline  (Cabaser®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lisuride Maleate

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Pergolide

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ropinirole  (Adartrel®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Medicines which are suitable to be prescribed in primary care only after specialist recommendation. Ongoing prescribing by primary care includes titration of dose and assessment of efficacy. There is no need for ongoing monitoring other than for general adverse effects as listed in the BNF & SPC.  

Amber Shared Care

Medicines which are suitable to be prescribed in primary care only after specialist recommendation only under a shared care protocol once the patient has been stabilised. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must be approved by the Harrogate & Rurual District Area Prescribing Committee (HaRD APC).   

Black

Medicines which the Harrogate & Rural District Area Prescribing Committee (HaRD APC) has reviewed and does not recommend for use at present based on a review of clinical and/or cost effectiveness data.   

Green

Medicines suitable for routine use and can be prescribed within primary care within their licensed indication in accordance with nationally recognised formularies e.g. BNF, BNF for Children, Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.  

Grey

Medicines which the Harrogate & Rural District Area Prescribing Committee (HaRD APC) have not yet reviewed.   

Red

Medicines for hospital use only. The responsibility for initiation and monitoring treatment should rest with an appropriate hospital clinician. The drug should be supplied by the hospital for the duration of the treatment course. Primary care prescriber initiation or continuation of treatemnt is not recommended.  

netFormulary